Rapid Micro Biosystems, Inc. announced its Q4 2025 financial results, reporting a 37% revenue growth to $11.3 million. The company also secured a multi-system order from Samsung Biologics, enhancing its Growth Direct platform deployment.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.